Skip to main content
Caplight Logo









EPINTEK

EPINTEK

Private
ShanghaiHealthcare & Life Scienceshttps://epintek.com/

Last Round

Series C

Extension

Aug 28, 2023

Total Funding Raised

$18.45M

Company Overview

EPINTEK is a healthcare services company that provides contract research organization (CRO) services, including preclinical research, analytical testing, regulatory strategy, and clinical trials for medical device and biomedical companies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Compliance, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract research organizationCROmedical device testingregulatory consultingclinical trial managementbiocompatibility testingmedical device registrationCDMOcontract development and manufacturingpreclinical researchmedical device compliancelab testing servicesmedtech consultingregulatory affairsbiostatistics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EPINTEK Comparables

Compare EPINTEK with similar companies based on industry and business-model similarity.

EPINTEK comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing Zhongguancun Shuimu Medical Technology Co., Ltd.
93%
天津海河生物医药科技集团有限公司
88%
Osmunda Medical Device Service Group
83%

EPINTEK Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionAug 28, 2023
Series C ExtensionJan 30, 2022

Key People

Founding team and executive leadership

Yu Rui

Chief Executive Officer

Executive Team

EPINTEK Investors

Notable investors and investment history

EPINTEK investors
InvestorRounds
October CapitalSeries C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2025

    Monthly visitors grew 1445% MoM, from 123 to 1.9K.

  • Aug 28, 2023

    $2.75M round led by October Capital

EPINTEK Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EPINTEK Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EPINTEK's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range8
Year Founded2020
Last FundingAug 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?